Robeco Institutional Asset Management
SAGE

Robeco Institutional Asset Management’s Sage Therapeutics SAGE Stock Holding History

Robeco Institutional Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,511
Closed -$480K – 958
2022
Q1 		$480K Sell
14,511
-20,619
-59% -$775K ﹤0.01% 777
2021
Q4 		$1.49M Buy
35,130
+7,532
+27% +$315K ﹤0.01% 670
2021
Q3 		$1.22M Buy
27,598
+24,485
+787% +$1.12M ﹤0.01% 694
2021
Q2 		$177K Buy
+3,113
New +$220K ﹤0.01% 892

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Robeco Institutional Asset Management's SAGE Position: Q2 2022 in Review

Robeco Institutional Asset Management sold out of Sage Therapeutics (SAGE) in Q2 2022, closing a stake of 14,511 shares — an estimated $480K sold.

Robeco Institutional Asset Management first reported a position in SAGE in Q2 2021 and held it in 4 quarters. The position peaked at $1.49M in Q4 2021. 210 funds tracked by Wall St. Rank hold SAGE as of Q2 2022.

  • Robeco Institutional Asset Management reported no remaining Sage Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 14,511 Sage Therapeutics shares in Q2 2022, an estimated $480K.
  • Robeco Institutional Asset Management first reported a position in Sage Therapeutics in Q2 2021 and held it in 4 quarters.
  • Robeco Institutional Asset Management's Sage Therapeutics position peaked at $1.49M in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2022.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2022, filed 27 Jul 2022.